Literature DB >> 20738322

Cutaneous adverse drug reactions in a hospital-based Chinese population.

H-Y Huang1, X-Q Luo, L-S Chan, Z-H Cao, X-F Sun, J-H Xu.   

Abstract

BACKGROUND: Cutaneous adverse drug reactions (CADRs) are common skin adverse reactions associated with drugs. AIM: To assess recent trends in CADRs and the drugs associated with them, using data from the past 5 years in the largest single database available on a hospital-based population in China.
METHODS: All clinical records of inpatients admitted with a diagnosis of CADR to the Dermatology Ward, Huashan Hospital from January 2004 to December 2008 were retrospectively studied.
RESULTS: In the 734 patients, the three most common types of CADRs were nonsevere reactions, erythema multiforme (EM)-like eruptions (n = 255), urticaria (n = 192) and exanthematous reactions (n = 159), followed by three severe reactions: Stevens-Johnson syndrome (n = 58), toxic epidermal necrolysis (n = 29) and exfoliative dermatitis (n = 22). The most common single drug associated with the development of all drug eruptions was allopurinol, followed by amoxicillin, cephalosporins, antiepileptic agents and antipyretic/analgesic agents. However, the most common single drugs associated with severe reactions were antiepileptic agents, followed by allopurinol, antipyretic/analgesic agents and cephalosporins. In contrast to patients with nonsevere reactions, patients with severe reactions were more likely to be male (P < 0.001) and to have a greater mean age of onset (P < 0.001), a longer latency period (P < 0.001) and a longer duration of hospitalization (P < 0.001).
CONCLUSION: In contrast to previous studies, we found allopurinol to be the most common single drug associated with CADRs followed by antibiotics (amoxicillin and cephalosporins), and antiepileptic, especially carbamazepine. A higher incidence of EM-like eruptions and urticaria was also seen.
© 2010 The Author(s). © 2010 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738322     DOI: 10.1111/j.1365-2230.2010.03922.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  10 in total

1.  HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population.

Authors:  Qinyuan Zhu; Yanzhou Zhang; Jiekun Xuan; Fanping Yang; Binbin Du; Sheng-An Chen; Sijia Yan; Menglin Jiang; Huizhong Zhu; Hao Xiong; Xiaoqun Luo; Qinghe Xing
Journal:  Pharmacogenomics J       Date:  2019-12-03       Impact factor: 3.550

Review 2.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

3.  Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.

Authors:  Israa Alfares; Muhammad Shahid Javaid; Zhibin Chen; Alison Anderson; Ana Antonic-Baker; Patrick Kwan
Journal:  CNS Drugs       Date:  2021-02-12       Impact factor: 5.749

4.  Severe cutaneous reactions to drugs in the setting of a general hospital.

Authors:  Luciana Rosa Grando; Tatiana Aline Berger Schmitt; Renato Marchiori Bakos
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

5.  Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.

Authors:  Ranjana Beniwal; Lalit Kumar Gupta; Ashok Kumar Khare; Asit Mittal; Sharad Mehta; Manisha Balai
Journal:  Indian Dermatol Online J       Date:  2019 Jan-Feb

6.  Diagnostic Utility of Human Leukocyte Antigen B*15:02 Screening in Severe Carbamazepine Hypersensitivity Syndrome.

Authors:  Youssef Moutaouakkil; Badr Adouani; Yahia Cherrah; Jamal Lamsaouri; Yassir Bousliman
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

7.  Clinical aspects and therapeutic approach of drug-induced adverse skin reactions in a quaternary hospital: a retrospective study with 219 cases.

Authors:  Júlia Chain Martins; Camila Arai Seque; Adriana Maria Porro
Journal:  An Bras Dermatol       Date:  2022-04-02       Impact factor: 2.113

8.  Compound-honeysuckle-induced drug eruption with special manifestations: A case report.

Authors:  Li-Feng Zhou; Rong Lu
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

9.  HLA-B*58:01 screening to prevent allopurinol-induced severe cutaneous adverse reactions in Chinese patients with chronic kidney disease.

Authors:  Christina Sze-Man Wong; Chi-Keung Yeung; Chun-Yin Chan; Desmond Yat-Hin Yap; Sydney Chi-Wai Tang; Bernard Man-Yung Cheung; Janette Siu-Yin Kwok; Henry Hin-Lee Chan
Journal:  Arch Dermatol Res       Date:  2021-07-02       Impact factor: 3.033

10.  The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.

Authors:  Shang-Chen Yang; Sindy Hu; Sheng-Zheng Zhang; Jin-Wen Huang; Jing Zhang; Chao Ji; Bo Cheng
Journal:  J Immunol Res       Date:  2018-02-11       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.